Subject(s)

Carbazoles/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Coronavirus Infections/therapy , Lung Neoplasms/drug therapy , Piperidines/therapeutic use , Pneumonia, Viral/therapy , Aged , Anaplastic Lymphoma Kinase/antagonists & inhibitors , Anaplastic Lymphoma Kinase/metabolism , Anti-HIV Agents/therapeutic use , Betacoronavirus/isolation & purification , COVID-19 , Carbazoles/pharmacology , Carcinoma, Non-Small-Cell Lung/complications , Carcinoma, Non-Small-Cell Lung/diagnosis , Carcinoma, Non-Small-Cell Lung/pathology , Coronavirus Infections/complications , Coronavirus Infections/diagnosis , Coronavirus Infections/drug therapy , Coronavirus Infections/virology , Drug Combinations , Humans , Hydroxychloroquine/therapeutic use , Lopinavir/therapeutic use , Lung/diagnostic imaging , Lung Neoplasms/complications , Lung Neoplasms/diagnosis , Lung Neoplasms/pathology , Male , Masks , Noninvasive Ventilation/instrumentation , Pandemics , Piperidines/pharmacology , Pneumonia, Viral/complications , Pneumonia, Viral/diagnosis , Pneumonia, Viral/virology , Ritonavir/therapeutic use , SARS-CoV-2 , Tomography, X-Ray Computed , Treatment Outcome , COVID-19 Drug Treatment